Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis-Reference-Cited by-同舟云学术

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis

Published:2008-07 Issue:7 Volume:26 Page:1282-1289
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Reboldi Gianpaolo,Angeli Fabio,Cavallini Claudio,Gentile Giorgio,Mancia Giuseppe,Verdecchia Paolo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference39 articles.

1. The clinical use of angiotensin-converting enzyme inhibitors;Wong;Prog Cardiovasc Dis,2004

2. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.;Lancet,2003

3. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003;Staessen;J Hypertens,2003

4. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.;J Hypertens,2007

5. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention;Verdecchia;Hypertension,2005

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations Between Hypertension, Angiotensin-Converting Enzyme Inhibitors, and Physical Performance in Very Old Adults: Results from the ilSIRENTE Study;The Journal of Frailty & Aging;2024

2. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

3. Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs;Expert Opinion on Drug Safety;2023-02-01

4. Endoplasmic reticulum stress: A common pharmacologic target of cardioprotective drugs;European Journal of Pharmacology;2022-09

5. Over-Prescription of the Imidazoline Receptor Agonists: Evidence for Restriction of the Therapeutic Indication;Therapeutic Innovation & Regulatory Science;2022-07-30